KATIE CHEN: Open Payments
NPI 1528714011 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 7 payments from 5 companies in 2025. Trend: 2023 $724 · 2024 $868 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $125 |
| PFIZER INC. | 1 | $90 |
| DePuy Synthes Sales Inc. | 3 | $57 |
| MML US, Inc. | 1 | $33 |
Products named: SPINRAZA, VYVGART, HYMPAVZI, TRUMATCH, ReActiv8.
Industry payments across CA — which companies pay providers there.
